Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05049967 · ClinicalTrials.gov registry record
iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders
A clinical trial of Genetic Disease, sponsored by Illumina.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05049967: Active study of Genetic Disease, sponsored by Illumina.
NCT05049967 is a study of Genetic Disease that is active but no longer recruiting, run by Illumina. The registered enrollment target is 150 participants, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05049967, a study of Genetic Disease, is active but no longer recruiting, sponsored by Illumina.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective observational study to further understand the value that a multi-omic approach has in individuals with a multi system, early onset disorder that does not have a molecular diagnosis by whole genome sequencing.
Conditions Studied
Study Locations (1)
Pennsylvania
- Clinic for Special Children - Strasburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2024-12-31 |
What the registry record for NCT05049967 still lists
NCT05049967 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05049967 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05049967 about?
NCT05049967 is a clinical study titled "iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders". Prospective observational study to further understand the value that a multi-omic approach has in individuals with a multi system, early onset disorder that does not have a molecular diagnosis by whole genome sequencing.
What is the current status of trial NCT05049967?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2021-11-09. Estimated completion is 2024-12-31.
What conditions does trial NCT05049967 study?
This clinical trial studies the following conditions: Genetic Disease.
Who is sponsoring clinical trial NCT05049967?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05049967 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05049967's enrollment target sits among peer trials
150 17th of 30 higher than 13 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI